A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Phase 2
340
about 3.3 years
18+
52 sites in AL, AZ, CA +16
About this study
Researchers are testing two trial medicines, PF-07275315 and PF-07264660, in people with moderate to severe atopic dermatitis. It is seeking participants who have confirmed atopic dermatitis for at least 6 months and are not having an effective treatment result from medicines that are applied on skin for AD. Participants will receive either PF-07275315 or PF-07264660 or placebo as multiple shots in the clinic over the course of each Stage.
Based on ClinicalTrials.gov records.
What participants do
- 1.Placebo
- 2.Take PF-07264660
- 3.Take PF-07275315
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Secondary: The number and % of participants achieving a Percent change from baseline in EASI total score at scheduled time points, The number and % of participants with treatment emergent AEs
Dermatology